Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis.
about
Radiation therapy and esophageal cancerAdjuvant concurrent chemoradiation using intensity-modulated radiotherapy and simultaneous integrated boost for resected high-risk adenocarcinoma of the distal esophagus and gastro-esophageal junctionEp-CAM expression in squamous cell carcinoma of the esophagus: a potential therapeutic target and prognostic markerNeoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS)Long-term efficacy of perioperative chemoradiotherapy on esophageal squamous cell carcinomaPredicting response to neoadjuvant therapy in esophageal cancer.Current status of predictive biomarkers for neoadjuvant therapy in esophageal cancerNeoadjuvant treatment of esophageal cancer.Systematic review of health-related quality of life after esophagectomy for esophageal cancerMeta-analysis of postoperative efficacy in patients receiving chemoradiotherapy followed by surgery for resectable esophageal carcinoma.Impact of jejunostomy during esophagectomy for cancer on health related quality of lifeComparison Between Concurrent Chemoradiation Followed by Surgery vs. Surgery for Locally Advanced Cancer of EsophagusCisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomesA Meta-Analysis of Concurrent Chemoradiotherapy for Advanced Esophageal Cancer.Aggressive surgical resection does not improve survival in operable esophageal squamous cell carcinoma with N2-3 status.Phase I evaluation of TNFerade biologic plus chemoradiotherapy before esophagectomy for locally advanced resectable esophageal cancerTrimodal therapy in squamous cell carcinoma of the esophagus.Assessment of esophageal carcinoma undergoing concurrent chemoradiotherapy with quantitative dynamic contrast-enhanced magnetic resonance imaging.Survival outcomes of resected patients who demonstrate a pathologic complete response after neoadjuvant chemoradiation therapy for locally advanced esophageal cancer.Predictive and prognostic molecular markers in outcome of esophageal cancer.Crossroads in the combined-modality management of gastroesophageal junction carcinomas.Neoadjuvant hyperfractionated-accelerated radiotherapy with concomitant chemotherapy in esophageal cancer: phase II study.Using the Comprehensive Complication Index to Assess the Impact of Neoadjuvant Chemoradiotherapy on Complication Severity After Esophagectomy for Cancer.Multimodality therapy for the curative treatment of cancer of the esophagus and gastroesophageal junction.Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.Rad51 expression is a useful predictive factor for the efficacy of neoadjuvant chemoradiotherapy in squamous cell carcinoma of the esophagus.Neoadjuvant chemoradiotherapy for esophageal cancer: a review of meta-analyses.Histologic tumor type and the rate of complete response after neoadjuvant therapy for esophageal cancer.An expert opinion on esophageal cancer therapy.Esophageal cancer--the five year survivors.Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer.Dissection of lymph node metastases in esophageal cancer.Curative treatment of oesophageal carcinoma: current options and future developments.Multimodal treatment of esophageal cancer.Curative treatment of esophageal cancer; an evidenced based review.Multimodal treatment strategy for clinical T3 thoracic esophageal cancer.Outcomes in the management of esophageal cancer.Role of radiotherapy in the pre-operative management of carcinoma of the esophagus.Current status of and perspectives regarding neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.Value and application of trimodality therapy or definitive concurrent chemoradiotherapy in thoracic esophageal squamous cell carcinoma.
P2860
Q27026922-B61FFC83-9E37-4233-BE86-B9D28A220DF7Q30537735-C98EAD70-F67D-4C54-9B4A-8711DDA17548Q33247794-28D27060-D36F-4FB2-9219-ECA77A3CD0F0Q33387427-705121D8-3268-4EF0-B18D-C324087AB42DQ33764809-053673F0-7EC7-4536-8F0C-87A2D4191842Q34022135-5620193C-B84F-4CAB-A9E8-8A648F3082A1Q34048027-A9F0F1AB-D483-40F5-8F0F-92CC0D40782CQ34063710-08CAED31-D1D1-43EA-9BE8-2D9D5131D3F8Q34105122-3D0A16EF-6836-47FA-B5D8-E0E2E7F20D92Q34469077-75C6B1FD-FDBA-42AA-90B2-78533F945010Q34785954-6B3F4E31-3E95-4E02-9049-8AC75400EEAAQ34796876-1EBE4C28-E7CF-44DB-A061-87430413B7C9Q34902754-FCF3803D-3086-4ADA-BC6C-F32DCAEF8D05Q35653698-01A0EE74-F466-4E6D-8598-081D79146C94Q35891420-A5DCE167-7AA1-4F29-85FA-C73729F9F7EFQ35977197-EB1D5B49-C06C-4B75-BD9A-CD6F1AE2EC9EQ36105835-739CDA91-0453-43B0-A371-412C44C3F158Q36335500-DBD34D66-179E-482E-B3D5-0CF1E7158F89Q36461980-9037ABFF-0A3B-4FA2-94F9-C653AC5DB820Q36636695-6C6ECF4A-16A5-4835-B578-9360CE14F9C8Q37076597-F96201E2-00AC-4CDA-9D9A-A2DAB4C9BB44Q37285962-A4B98596-5389-4964-9FF6-F23738BD63F1Q37306494-30270B89-8897-46B5-896E-8880B824E63BQ37338260-2E081853-F399-47A3-9360-FAAB35B9ED30Q37449181-EA58B96D-3EA4-4EE4-848F-F89CF468C5D7Q37594158-FC6D7CBD-DB12-43FB-9DC6-FC7B58DD3890Q37598622-FFE0D1C3-039A-462B-A7DF-20E82D54E2CFQ37658761-DED138EB-3A9C-43A4-A131-86014D96746DQ37827871-29EB15B9-25B8-4CC4-8202-7DAADB8F0AAAQ37831846-CC059021-B30F-4A93-9605-D4ED5909F3D8Q37861088-64242ABE-3192-45D3-9E51-5D9F63A357A1Q37866789-9B49E105-D585-4463-9504-EA7011878F8AQ37880292-66CB3C3D-7B76-47C1-A30E-4B49F87C68C8Q38042808-21C849E4-DFA2-4FBB-9B2B-D7F5B2E6281CQ38119170-546AD72C-6BDD-4F4A-861E-8F4B6549E8F7Q38128743-8DBC3F6C-F329-4A07-808A-896B2A64A738Q38242093-8BDD005A-BB4B-4131-8ED6-25F981FA6452Q38327897-33258CF7-D166-4A03-A499-86C1C38AD6FFQ38367708-46A058EC-A4B2-4684-93FF-714A344B2197Q38728084-E114FEBA-D48C-4433-A015-2EE6FED21900
P2860
Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis.
@ast
Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis.
@en
type
label
Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis.
@ast
Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis.
@en
prefLabel
Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis.
@ast
Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis.
@en
P2093
P1433
P1476
Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis.
@en
P2093
John D Birkmeyer
John E Sutton
Philip P Goodney
Sarah E Greer
P304
P356
10.1016/J.SURG.2004.06.033
P407
P577
2005-02-01T00:00:00Z